The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 7,101–7,200 of 31,469
Circulating glutamate level as a potential biomarker for abdominal obesity and metabolic risk.
Maltais-Payette, I., Allam‐Ndoul, B., Pérusse, L., Vohl, M., & Tchernof, A. (2019) · NMCD. Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.08.015 · Cited by 50
Haloul, M., Vinjamuri, S., Naquiallah, D., Mirza, M. I., Qureshi, M., Hassan, C., Masrur, M. A., Bianco, F. M., Frederick, P., Cristoforo, G. P., et al. (2020) · Nutrients · doi:10.3390/nu12072014 · Cited by 52
Clinical features of familial Mediterranean fever: an Italian overview.
Manna, R., Cerquaglia, C., Curigliano, V., Fonnesu, C., Giovinale, M., Verrecchia, E., Montalto, M., Socio, G. D., Soriano, A., Regina, M. L., et al. (2009) · PubMed · Cited by 51
Kim, S. H., Hur, H. J., Yang, H. J., Kim, H., Kim, M. J., Park, J. H., Sung, M. J., Kim, M., Kwon, D. Y., & Hwang, J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/921012 · Cited by 51
High prevalence of glucose intolerance even among young adults in south India
Raghupathy, P., Antonisamy, B., Fall, C. H. D., Geethanjali, F. S., Leary, S. D., Saperia, J., Priya, G., Rajaratnam, A., & Richard, J. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.12.005 · Cited by 51
Berthiaume, M., Sell, H., Lalonde, J., Gélinas, Y., Tchernof, A., Richard, D., & Deshaies, Y. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00339.2004 · Cited by 51
Echiburú, B., Pérez‐Bravo, F., Maliqueo, M. A., Sánchez, F., Crisosto, N., & Sir‐Petermann, T. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.002 · Cited by 51
Marques-Vidal, P. M., Velho, S., Waterworth, D. M., Waeber, G., von Känel, R., & Vollenweider, P. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.170 · Cited by 52
Reduced Adiponectin Level Is Associated With Severity of Coronary Artery Disease
Hara, K., Yamauchi, T., Imai, Y., Manabe, I., Nagai, R., & Kadowaki, T. (2007) · International Heart Journal · doi:10.1536/ihj.48.149 · Cited by 51
Barbieri, M., Rizzo, M. R., Papa, M., Acampora, R., Angelis, L. D., Olivieri, F., Marchegiani, F., Franceschi, C., & Paolisso, G. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.05.004 · Cited by 50
Klinke, D. J. (2007) · Annals of Biomedical Engineering · doi:10.1007/s10439-007-9410-y · Cited by 51
Hypertriglyceridaemia in Alström's syndrome: causes and associations in 37 cases
Paisey, R., Carey, C., Bower, L., Marshall, J. D., Taylor, P., Maffei, P., & Mansell, P. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01952.x · Cited by 50
Haupt, D. W., Fahnestock, P. A., Flavin, K. S., Schweiger, J. A., Stevens, A., HESSLER, M. J., Maeda, J. A., Yingling, M. D., & Newcomer, J. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301392 · Cited by 51
Kaya, C., Erkan, A. F., Cengiz, S. D., Dünder, İ., Demirel, Ö., & Bi̇lgi̇han, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.016 · Cited by 51
Lim, S. K., Yoon, J. W., Choi, S. H., Park, Y. J., Lee, J. J., Park, J. H., Lee, S. B., Kim, K. W., Lim, J., Kim, Y., et al. (2009) · Obesity · doi:10.1038/oby.2009.232 · Cited by 51
Effect of Exercise Therapy on Monocyte and Neutrophil Counts in Overweight Women
Node, K., Michishita, R., Tsuruta, T., Shono, N., & Inoue, T. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181c6a980 · Cited by 52
Lawlor, D. A., Smith, G. D., & Ebrahim, S. B. J. (2003) · Paediatric and Perinatal Epidemiology · doi:10.1046/j.1365-3016.2003.00479.x · Cited by 51
Zhang, H. ‐., Ji, B., Chen, G., Zhou, F. L., Luo, Y., Yu, H., Gao, F., Zhang, Z. ‐., & Li, H. ‐. (2009) · Journal of Food Science · doi:10.1111/j.1750-3841.2008.00976.x · Cited by 53
Doğru, T., Genç, H., Tapan, S., Erçin, C. N., Örs, F., Aslan, F., Kara, M., Sertoğlu, E., Bağcı, S., Kurt, İ., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.11.022 · Cited by 51
Moore, A. F., Jablonski, K. A., Mason, C. C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1583 · Cited by 51
Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats
Castilla‐Cortázar, I., Garcia‐Fernandez, M. I., Delgado, G., Puche, J. E., Sierra, I., Barhoum, R., & González-Barón, S. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-103 · Cited by 51
Zheng, R.-D., Xu, C.-R., Li, J., et al. (2010) · International Journal of Medical Sciences · doi:10.7150/ijms.7.272 · Cited by 51
Křížová, J., Dolinkova, M., Lacinová, Z., Sulek, S., Doležalová, R., Housova, J., Krajickova, J., Haluzíková, D., Bošanská, L., Papežová, H., et al. (2008) · Physiological Research · doi:10.33549/physiolres.931195 · Cited by 51
Kuk, J. L., Kilpatrick, K., Davidson, L. E., HUDSON, R. W., & Ross, R. L. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-060 · Cited by 51
Inflammation Warms Up the Metabolic Syndrome
Esposito, K., Ciotola, M., & Giugliano, D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000185830.17528.e3 · Cited by 50
Thulé, P. M., Campbell, A. G., Kleinhenz, D. J., Olson, D. E., Boutwell, J., Sutliff, R. L., & Hart, C. M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00134.2005 · Cited by 51
Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis
Ebert, T., Bachmann, A., Lössner, U., Kratzsch, J., Blüher, M., Stümvoll, M., & Faßhauer, M. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.016 · Cited by 51
Sleep-Disordered Breathing and Metabolic Effects: Evidence from Animal Models
Jun, J. C., & Polotsky, V. Y. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.03.009 · Cited by 52
The effect of exercise training on adiponectin receptor expression in KKAy obese/diabetic mice
Hu, H., Iida, K., Sone, H., Yokoo, T., Yamada, N., & Ajisaka, R. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06630 · Cited by 51
Panhuysen, C. I. M., Cupples, L. A., Wilson, P. W. F., Herbert, A. G., Myers, R. H., & Meigs, J. B. (2003) · Diabetologia · doi:10.1007/s00125-003-1066-z · Cited by 52
Hoefle, G., Saely, C. H., Aczél, S., Benzer, W., Marte, T., Langer, P. H., & Drexel, H. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802985 · Cited by 49
Hahn, S., Backhaus, M., Broecker‐Preuss, M., Tan, S., Dietz, T., Kimmig, R., Schmidt, M., Mann, K., & Janssen, O. E. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0143 · Cited by 51
Belfiore, F., Iannello, S., Camuto, M., Fagone, S., & Cavaleri, A. (2001) · Metabolism: Clinical and Experimental · doi:10.1053/meta.2001.22518 · Cited by 56
Acute Hyperlipidemia Increases Oxidative Stress More in African Americans Than in White Americans
Lopes, H. F. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00041-4 · Cited by 51
Cho, Y. M., Park, K. S., Jung, H. S., Jeon, H. J., Ahn, C., Ha, J., Kim, S. J., Rhee, B. D., Kim, S. Y., & Lee, H. K. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1123 · Cited by 51
Prediction of Insulin Sensitivity in Nonobese Women with Polycystic Ovary Syndrome
Cibula, D., Škrha, J., Hill, M., Fanta, M., Haaková, L., Vrbíková, J., & Zivny, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020586 · Cited by 50
Kanauchi, M., Yamano, S., Kanauchi, K., & Saito, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021641 · Cited by 51
Clapham, J., Smith, S., Moore, G., Hughes, M., Azam, H., Scott, A. M., & Jung, R. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800384 · Cited by 50
Keulen, E. T. P., Kruijshoop, M., Schaper, N. C., Hoeks, A. P. G., & de Bruin, T. W. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104100 · Cited by 51
Koo, B. K., Roh, E., Yang, Y. S., & Moon, M. K. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12392 · Cited by 48
Shang, W., Zhang, Y., Wang, G., & Han, D. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14247 · Cited by 50
“A commonly used surrogate estimate of insulin resistance was HOMA-IR.(29) The method uses fasting insulin and glucose concentrations to measure insulin resistance and correlates reasonably with the results of clamping studies.”
Lanzi, S., Codecasa, F., Cornacchia, M., Maestrini, S., Salvadori, A., Brunani, A., & Malatesta, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088707 · Cited by 50
Xu, M., Li, X. Y., Wang, J. G., Wang, X. J., Huang, Y., Cheng, Q., Huang, H. E., Li, R., Xiang, J., Tan, J. R., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1386-8 · Cited by 50
Viscoli, C. M., Brass, L. M., Carolei, A., Conwit, R., Ford, G. A., Furie, K. L., Gorman, M., Guarino, P. D., Inzucchi, S. E., Lovejoy, A. M., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.07.016 · Cited by 50
Daka, B., Rosen, T., Jansson, P. A., Råstam, L., Larsson, C. A., & Lindblad, U. (2013) · Endocrine Connections · doi:10.1530/ec-12-0057 · Cited by 50
Glucose-Raising Genetic Variants in MADD and ADCY5 Impair Conversion of Proinsulin to Insulin
Wagner, R., Dudziak, K., Herzberg-Schäfer, S. A., Machicao, F., Stefan, N., Staiger, H., Häring, H.-U., & Fritsche, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023639 · Cited by 50
Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals
Slusher, A. L., Whitehurst, M., Zoeller, R. F., Mock, J. T., Maharaj, M., & Huang, C.-J. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.06.002 · Cited by 50
Moro, C., Pillard, F., de Glisezinski, I., Klimcakova, E., Crampes, F., Thalamas, C., Harant, I., Marques, M.-A., Lafontan, M., & Berlan, M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90227.2008 · Cited by 56
Russo, G. I., Cimino, S., Fragalà, E., Privitera, S., Vignera, S. L., Condorelli, R. A., Calogero, A. E., Castelli, T., Favilla, V., & Morgia, G. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12587 · Cited by 52
Jin, C., Lin, L., Han, N., Zhao, Z., Liu, Z., Luo, S., Xu, X., Liu, J., & Wang, H. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-019-0425-9 · Cited by 51
Ribeiro, V. B., Kogure, G. S., Lopes, I. P., Silva, R. C., Pedroso, D. C. C., de Melo, A. S., de Souza, H. C. D., Ferriani, R. A., Furtado, C. L. M., & dos Reis, R. M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14194 · Cited by 54
Khlifi, R., Dhaouefi, Z., Toumia, I. B., Lahmar, A., Sioud, F., Bouhajeb, R., Bellalah, A., & Ghédira, L. C. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108490 · Cited by 51
Kaempferide improves glycolipid metabolism disorder by activating PPARγ in high-fat-diet-fed mice
Tang, H. Y., Zeng, Q., Tang, T. S., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119133 · Cited by 50
Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease
Hopp, K., Catenacci, V. A., Dwivedi, N., Kline, T. L., Wang, W., You, Z., Nguyen, D. T., Bing, K., Poudyal, B., Johnson, G. C., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103697 · Cited by 52
Rivière, B., Jaussent, A., Macioce, V., Faure, S., Builles, N., Lefebvre, P., Géraud, P., Picot, M., Rebuffat, S. A., Renard, É., et al. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101345 · Cited by 50
Martino, M. R., Gutiérrez‐Aguilar, M., Yiew, N. K. H., Lutkewitte, A. J., Singer, J., McCommis, K. S., Ferguson, D., Liss, K. H. H., Yoshino, J., Renkemeyer, M. K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110733 · Cited by 47
Bhupathiraju, S. N., Sawicki, C. M., Goon, S., Gujral, U. P., Hu, F. B., Kandula, N. R., & Kanaya, A. M. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac174 · Cited by 53
Amaravadi, S. K., Maiya, A. G., Vaishali, K., & Shastry, B. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302831 · Cited by 65
Auriemma, R. S., Grasso, L. F. S., Galdiero, M., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0995-5 · Cited by 50
Börnhorst, C., Tilling, K. M., Russo, P., Kourides, Y., Michels, N., Molnár, D., Rodriguez, G. P., Moreno, L. A., Krogh, V., Ben‐Shlomo, Y., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0080-z · Cited by 49
Adoptive Transfer of Syngeneic Bone Marrow-Derived Cells in Mice with Obesity-Induced Diabetes
Chen, J., Li, H., Addabbo, F., Zhang, F., Pelger, E., Patschan, D., Park, H. C., Kuo, M., Ni, J., Gobe, G. C., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080606 · Cited by 50
Aşık, M., Altınbaş, K., Eroğlu, M., Karaahmet, E., Erbag, G., Ertekin, H., & Şen, H. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.043 · Cited by 41
Huh, J. H., Choi, S. I., Lim, J. S., Chung, C. H., Shin, J. Y., & Lee, M. Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133062 · Cited by 50
Weil, B. R., Mestek, M. L., Westby, C. M., Guilder, G. P. V., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y10-046 · Cited by 51
Haemer, M. A., Grow, H. M., Fernandez, C., Lukasiewicz, G., Rhodes, E. T., Shaffer, L. A., Sweeney, B. R., Woolford, S. J., & Estrada, E. (2014) · Childhood Obesity · doi:10.1089/chi.2013.0158 · Cited by 50
Bizzarri, C., Pinto, R. M., Ciccone, S., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25603 · Cited by 50
Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease
Yun, J. W., Cho, Y. K., Park, J. H., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01920.x · Cited by 50
Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus
Lekva, T., Bollerslev, J., Norwitz, E. R., Aukrust, P., Henriksen, T., & Ueland, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136892 · Cited by 51
Agrawal, S., Sharma, S. K., Sreenivas, V., & Ramakrishnan, L. (2011) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.90988 · Cited by 51
Prakash, J., Srivastava, N., Awasthi, S., et al. (2011) · Annals of Human Biology · doi:10.3109/03014460.2011.614278 · Cited by 50
Macauley, M., Smith, F. E., Thelwall, P. E., Hollingsworth, K. G., & Taylor, R. (2015) · Clinical Science · doi:10.1042/cs20140681 · Cited by 50
Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes
Sullivan, T. J., Miao, Z., Zhao, B. N., Ertl, L. S., Wang, Y., Krasinski, A., Walters, M. J., Powers, J. P., Dairaghi, D. J., Baumgart, T., et al. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.008 · Cited by 56
Combining enteral with parenteral nutrition to improve postoperative glucose control
Lidder, P. G., Flanagan, D., Fleming, S., Russell, M. A., Morgan, N. G., Wheatley, T., Rahamin, J., Shaw, S. R., & Lewis, S. J. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114509993631 · Cited by 50
Côté, N., Pîbarot, P., Pépin, A., Fournier, D., Audet, A., Arsenault, B. J., Couture, C., Poirier, P., Després, J., & Mathieu, P. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.05.054 · Cited by 50
Tandon, N., Garg, M. K., Singh, Y., & Marwaha, R. K. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0020 · Cited by 48
Gilardini, L., Parati, G., Sartório, A., Mazzilli, G., Pontiggia, B., & Invitti, C. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002288 · Cited by 50
Birth-weight, insulin levels, and HOMA-IR in newborns at term
Simental‐Mendía, L. E., Castañeda-Chacón, A., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-94 · Cited by 50
Jo, S.-K., Lee, W., Rhee, E., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.035 · Cited by 50
Mean Platelet Volume in Obese Adolescents with Nonalcoholic Fatty Liver Disease
Arslan, N., & Makay, B. B. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.130 · Cited by 50
Darendelıler, F., Aycan, Z., Çetinkaya, E., Vidilisan, S., Baş, F., Bıdecı, A., Demirel, F., Darcan, Ş., Büyükgebiz, A., Yıldız, M., et al. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098440 · Cited by 51
Siervo, M., Riley, H. L., Fernandez, B. O., Leckstrom, C. A., Martín, D., Mitchell, K., Levett, D. Z. H., Montgomery, H., Mythen, M. G., Grocott, M. P. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094915 · Cited by 50
Therapeutic vaccine against DPP4 improves glucose metabolism in mice
Pang, Z., Nakagami, H., Osako, M. K., Koriyama, H., Nakagami, F., Tomioka, H., Shimamura, M., Kurinami, H., Takami, Y., Morishita, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322009111 · Cited by 50
Common Variant ofFTOGene, rs9939609, and Obesity in Pakistani Females
Shahid, A., Rana, S., Saeed, S., Imran, M., Afzal, N., & Mahmood, S. (2013) · BioMed Research International · doi:10.1155/2013/324093 · Cited by 49
Post‐transplant diabetes mellitus in children following renal transplantation
Prókai, Á., Fekete, A., Kis, É., Reusz, G., Sallay, P., Körner, A., Wagner, L. J., Tulassay, T., & Szabo, A. J. (2008) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00862.x · Cited by 50
Jwa, H., Choi, Y., Park, U., Um, S., Yoon, S. K., & Park, T. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.009 · Cited by 50
Human serum acylcarnitine profiles in different glucose tolerance states
Zhang, X., Zhang, C., Chen, L., Han, X., & Ji, L. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.013 · Cited by 50
Association between insulin resistance and periodontitis in Korean adults
Lim, S. G., Han, K., Kim, H., Pyo, S. W., Cho, Y., Kim, K. S., Yim, H. W., Lee, W., Park, Y. G., & Park, Y. (2013) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12196 · Cited by 50
Phillips, C. M., Goumidi, L., Bertrais, S., Ferguson, J. F., Field, M. R., Kelly, E. D., Mehegan, J., Peloso, G. M., Cupples, L. A., Shen, J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1081 · Cited by 50
Rendo‐Urteaga, T., de Moraes, A. C. F., Collese, T. S., Μanios, Y., Hagströmer, M., Sjöström, M., Kafatos, A., Widhalm, K., Vanhelst, J., Marcos, A., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.176 · Cited by 52
Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism
Altınova, A. E., Törüner, F. B., Aktürk, M., Bukan, N. C., Çakır, N., Ayvaz, G., & Arslan, M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02628.x · Cited by 50
Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes
Uno, T., Ohsawa, I., Tokudome, M., & Sato, Y. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.017 · Cited by 50
Chistiakov, D. A., Potapov, V. A., Khodirev, D. C., Шамхалова, М. Ш., Shestakova, M. V., & Nosikov, V. V. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0056-5 · Cited by 50
Androgens in the maternal and fetal circulation: association with insulin resistance
Morisset, A., Dubé, M., Drolet, R., Pelletier, M., Labrie, F., Luu-The, V., Tremblay, Y., Robitaille, J., Weisnagel, S. J., & Tchernof, A. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.735725 · Cited by 50
Shi, Y., & Pan, T. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101194f · Cited by 50
Valderas, J., Irribarra, V., Rubio, L., Boza, C., Escalona, M., Liberona, Y., Matamala, A., & Maíz, A. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0375-4 · Cited by 56
Annagür, B. B., Tazegül, A., Uğuz, F., Kerimoğlu, Ö. S., Tekinarslan, E., & Çelık, Ç. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.01.002 · Cited by 50
Wongwananuruk, T., Rattanachaiyanont, M., Leerasiri, P., Indhavivadhana, S., Techatraisak, K., Angsuwathana, S., Tanmahasamut, P., & Dangrat, C. (2012) · International Journal of Endocrinology · doi:10.1155/2012/571035 · Cited by 53
Lin, C.-H., Lee, Y., Huang, Y., Hsieh, S., Chen, Z.-S., & Tsai, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/176949 · Cited by 51
Mazza, A., Fruci, B., Guzzi, P. H., D'Orrico, B., Malaguarnera, R., Veltri, P., Fava, A., & Belfiore, A. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.04.016 · Cited by 50
Yano, Y., Hoshide, S., Ishikawa, J., et al. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.12.008 · Cited by 50
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
